Previous 10 | Next 10 |
The Wearable Medical Devices Market size is expected to be worth around USD 196.7 billion by 2030 valued at USD 21.7 billion in 2021 and growing at a CAGR of 28.3% during the forecast period from 2022 to 2030. This comprehensive analysis of the fastest-growing Wearable Medical...
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announce that it is one of only eight companies selected to present at the 2nd Annual Innovation Showca...
REDWOOD CITY, CA / ACCESSWIRE / January 26, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it has signed its second distribution agreement with a top five US medical device distributor for the...
REDWOOD CITY, CA / ACCESSWIRE / January 23, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference,...
REDWOOD CITY, CA / ACCESSWIRE / January 17, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has signed an agreement with a leading group purchasing organization ("GPO") for national distri...
Designed to support revenue growth by expanding biotres form factors for the early detection of cardiac arrhythmias in the $5 billion-dollar holter monitor market REDWOOD CITY, CA / ACCESSWIRE / December 12, 2022 / Biotricity, Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a medical d...
Company Delivers Revenue Growth in 9 Out of the last 10 Consecutive Quarters REDWOOD CITY, CA / ACCESSWIRE / November 21, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it has sur...
Recent announcement with Top 10 National Medical Distributor underscores Company's expanded footprint REDWOOD CITY, CA / ACCESSWIRE / November 18, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, provi...
REDWOOD CITY, CA / ACCESSWIRE / November 16, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, has signed a distribution agreement with one of the Top 10 US medical device distributors . to distribute its ca...
Biotricity, Inc. (BTCY) Q2 2023 Earnings Conference Call November 14, 2022 04:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Waqaas Al-Siddiq - Chairman, Chief Executive Officer & Founder John Ayanoglou - Chief F...
News, Short Squeeze, Breakout and More Instantly...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...
REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach t...
REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group enco...